Видео ютуба по тегу Summit Therapeutics Lung Cancer

Summit Therapeutics Co-CEOs on what's next for lung cancer drug
Summit Therapeutics Co-CEOs on what's next for lung cancer drug
CAR T-Cell Therapy in Small Cell Lung Cancer - Lung Cancer Key Developments OncPanel 2025-26
CAR T-Cell Therapy in Small Cell Lung Cancer - Lung Cancer Key Developments OncPanel 2025-26
Updates in EGFR-Mutated Non-Small Cell Lung Cancer - Lung Cancer Key Developments OncPanel 2025-26
Updates in EGFR-Mutated Non-Small Cell Lung Cancer - Lung Cancer Key Developments OncPanel 2025-26
NGS Testing for MTAP Loss - Lung Cancer Key Developments OncPanel 2025-26
NGS Testing for MTAP Loss - Lung Cancer Key Developments OncPanel 2025-26
Summit Therapeutics Data From The Phase III HARMONi Trial Of Ivonescimab | Sep 08, 2025
Summit Therapeutics Data From The Phase III HARMONi Trial Of Ivonescimab | Sep 08, 2025
Hope Summit 2025: Learning the Basics of a Lung Cancer Diagnosis
Hope Summit 2025: Learning the Basics of a Lung Cancer Diagnosis
International Lung Cancer Summit
International Lung Cancer Summit
Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster - statnews.com
Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster - statnews.com
Why Summit Therapeutics (SMMT) Stock Plunged 20% in a Single Session
Why Summit Therapeutics (SMMT) Stock Plunged 20% in a Single Session
Ivonescimab Breakthrough: New Lung Cancer Drug Shows Superior Results!
Ivonescimab Breakthrough: New Lung Cancer Drug Shows Superior Results!
Chemotherapy-Free Intervals - Lung Cancer Key Developments OncPanel 2025-26
Chemotherapy-Free Intervals - Lung Cancer Key Developments OncPanel 2025-26
HOPE Summit 2025: Managing Central Nervous System Disease in Lung Cancer
HOPE Summit 2025: Managing Central Nervous System Disease in Lung Cancer
Updates in Cellular Therapies in NSCLC and SCLC - Lung Cancer Key Developments OncPanel 2025-26
Updates in Cellular Therapies in NSCLC and SCLC - Lung Cancer Key Developments OncPanel 2025-26
Lung Cancer Precision Medicine Summit
Lung Cancer Precision Medicine Summit
Updates in SCLC: Tarlatamab and Maintenance - Lung Cancer Key Developments OncPanel 2025-26
Updates in SCLC: Tarlatamab and Maintenance - Lung Cancer Key Developments OncPanel 2025-26
Summit Therapeutics (SMMT) Stock Drops 11.82% Despite Q3 Earnings Beat Amid Rising R&D Expenses
Summit Therapeutics (SMMT) Stock Drops 11.82% Despite Q3 Earnings Beat Amid Rising R&D Expenses
Updates in Immunotherapy - Lung Cancer Key Developments OncPanel 2025-26
Updates in Immunotherapy - Lung Cancer Key Developments OncPanel 2025-26
Hope Summit 2025: Integrative Medicine: Improving the Quality of Life During Lung Cancer Treatment
Hope Summit 2025: Integrative Medicine: Improving the Quality of Life During Lung Cancer Treatment
Ottawa Lung Cancer Summit
Ottawa Lung Cancer Summit
Halifax Lung Cancer Summit
Halifax Lung Cancer Summit
Developing Lung Cancer Screening Guidelines - 2022 Gastric Cancer Summit
Developing Lung Cancer Screening Guidelines - 2022 Gastric Cancer Summit
Большой риск — большая награда. Новое лекарство от рака. Анализ Summit Therapeutics, акции SMMT |...
Большой риск — большая награда. Новое лекарство от рака. Анализ Summit Therapeutics, акции SMMT |...
Telisotuzumab Vedotin for MET-Positive Non-Small Cell Lung Cancer - Lung Cancer OncInsights 2025-26
Telisotuzumab Vedotin for MET-Positive Non-Small Cell Lung Cancer - Lung Cancer OncInsights 2025-26
Summit Therapeutics to begin Phase 3 studies of ridinilazol this quarter
Summit Therapeutics to begin Phase 3 studies of ridinilazol this quarter
2025 Summit Speaker - Neel Gandhi, MD
2025 Summit Speaker - Neel Gandhi, MD